Licochalcone-A sensitizes human esophageal carcinoma cells to TRAIL-mediated apoptosis by proteasomal degradation of XIAP.
第一作者:
Pengfei,Yang
作者:
主题词
抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);癌(Carcinoma);细胞系, 肿瘤(Cell Line, Tumor);查耳酮类(Chalcones);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物协同作用(Drug Synergism);食管肿瘤(Esophageal Neoplasms);HEK293细胞(HEK293 Cells);人类(Humans);蛋白酶体内肽酶复合物(Proteasome Endopeptidase Complex);原癌基因蛋白质c-akt(Proto-Oncogene Proteins c-akt);TNF相关凋亡诱导配体(TNF-Related Apoptosis-Inducing Ligand);时间因素(Time Factors);转染(Transfection);X连锁凋亡抑制蛋白质(X-Linked Inhibitor of Apoptosis Protein)
PMID
25436288
发布时间
2017-11-16
- 浏览2
Hepato-gastroenterology
1229-34页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文